Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its patent foramen ovale occlusion system for patients with a PFO and ...

TCT 579: The Incidence of Atrial Fibrillation After Percutaneous Patent Foramen Ovale (PFO) Closure Detected by Implantable Loop Recorders (ILR) Receive the the latest news, research, and ...

- Patent Foramen Ovale (PFO) Closure Devices Market size is expected to rise by 2026 owing to increasing prevalence, escalating preferences for minimally-invasive, safety, technically feasible ...

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "PFO Closure Device Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. In a landscape shaped by evolving ...

W.L. Gore and Associates announced the FDA has granted a new indication for prevention of recurrent ischemic stroke for its patent foramen ovale closure device. The expanded approval of the device ...

Data indicate that there could be a link between cryptogenic thromboembolic events and patent foramen ovale (PFO). Although controversial, increasing numbers of patients are undergoing transcatheter ...

PARIS – Holistick Medical SAS reported a $5 million round for development of the first generation of a light-activated implant for a patent foramen ovale (PFO). Truffle Capital provided the startup ...

DUBLIN--(BUSINESS WIRE)--The "US Market Report for Patent Foramen Ovale Devices 2018 - MedCore" report has been added to Research and Markets' offering. Some studies have suggested that PFO closure ...

Evidence-based recommendations on percutaneous closure of the patent foramen ovale for the prevention of cerebral embolic stroke. This involves placing a small device into the heart to close the hole.

(MENAFN- GlobeNewsWire - Nasdaq) The PFO closure device market is driven by a shift to minimally invasive solutions and patient-centric care. Opportunities lie in transcatheter methods, bioresorbable ...